FOLH1 and prostate cancer: Similarly, PSMA × CD3 bispecific antibody constructs triggered Granzyme B and perforin-mediated prostate cancer cytolysis along with the release of cytokines such as IL-2 and interferon-gamma from redirected human T lymphocytes in co-culture assays [78].